"What isn't uncertain is this government's growth-at-all-costs agenda."
But as an investor focused on extending healthy human life, I’ve found the opposite to be true. Awards may be encouraging and occasionally useful for visibility, but they are weak indicators of validation and poor predictors of long-term success. In the longevity and healthspan industry, where timelines are long and claims are easy to overstate, venture capital ultimately follows alignment and evidence, not applause received at glitzy industry events.
。一键获取谷歌浏览器下载对此有专业解读
人 民 网 版 权 所 有 ，未 经 书 面 授 权 禁 止 使 用
2024年12月24日 星期二 新京报
Opening a manual page using a pop-up: